bacopasaponin C

triterpene glycoside from Indian medicinal plant Bacopa monniera (b. brahmi); a glycosidic pseudojujobogenin with glucose and rhamnose at the 3-position;

Also Known As:

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Aung, Hsu Mon: 1 article (02/2021)
2.	Duangkaew, Marisa: 1 article (02/2021)
3.	Huangteerakul, Chananya: 1 article (02/2021)
4.	Ingkaninan, Kornkanok: 1 article (02/2021)
5.	Jensen, Amornrat Naranuntarat: 1 article (02/2021)
6.	Jensen, Laran T: 1 article (02/2021)
7.	Sukrong, Suchada: 1 article (02/2021)
8.	Thosapornvichai, Thitipa: 1 article (02/2021)
9.	Kong, De Yun: 1 article (06/2010)
10.	Peng, Ling: 1 article (06/2010)

Related Diseases

1.	Colorectal Neoplasms (Colorectal Cancer) 02/24/2021 - "Bacopasaponin C may have potential as a drug candidate or serve as a model for the development of analogs for the treatment of colorectal cancer."
2.	Breast Neoplasms (Breast Cancer) 06/01/2010 - "The remaining two compounds, bacopaside II (2) and bacopasaponin C (4) were found to be much less potent compared with 1 and 3. 1 and 3 significantly inhibited human breast cancer cell line MDA-MB-231 adhesion, migration and Matrigel invasion in vitro at the concentration of 50 micromol/L. "
3.	Body Weight (Weight, Body) 01/01/2002 - "At equivalent dose of 1.75 mg/kg body weight, every third day for a total of 6 doses in 15 days, Bacopasaponin C in all the vesicular forms was found to be very active. "

Related Drugs and Biologics

1.	bacopaside II
2.	matrigel